Mirum Pharmaceuticals (NASDAQ: MIRM) is a biopharmaceutical company that develops and commercializes medicines for rare liver diseases. The filing excerpts provided do not contain sufficient detail to describe Mirum's specific revenue streams, product portfolio, commercial-stage assets, competitive position, geographic footprint, leadership, or financial metrics with the precision required by these writing rules. All material business facts have been omitted because they are not supported by the excerpts supplied from the 10-K filed 2026-02-25 (accession 000175942526000013).

Source: SEC 10-K, filed 2026-02-25

Industry: Pharmaceutical Preparations Peers: Arcellx Inc TG Therapeutics Inc IGM Biosciences, Inc. MannKind Corp Northwest Biotherapeutics Inc Viridian Therapeutics Inc Nuvalent, Inc Replimune Group Inc Sangamo Therapeutics Inc